Le Lézard
Classified in: Health
Subjects: AWD, NPT, TDS, FVT

Medical Science Liaison Society Announces Finalists for the 2019 MSL of the Year Awards


RALEIGH, N.C., Aug. 15, 2019 /PRNewswire/ -- The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, has announced the finalists for the 2019 MSL of the Year Awards.

Medical Science Liaison Society International Women's Day (PRNewsfoto/Medical Science Liaison Society)

The MSL of the Year Awards are free for all nominees and winners and recognizes excellence within the MSL profession. During the 7th Annual MSL Society Conference at the Awards Night Celebration, on September 4th at The Venetian Hotel in Las Vegas, both finalists and the winners will be honored.

The 2019 finalists include:

MSL Manager of the Year
Cristina Garcia ? Persan Farma
Debra Lycett ? Epizyme
Douglas Yau ? Sanofi Genzyme
Sherif Roushdy ? Sanofi
Susan Giacalone ? Lexicon Pharmaceuticals

MSL of the Year
Adina Hirsch ? Fresenius Kabi 
Alyson Evans ? Sun Pharma
Anne VanBuskirk ? Takeda Oncology
Joan Hester ? Alimera Sciences
Martina Riosalido ? Norgine 
Patty Riley ? CSL Behring
Sarah Rodriguez ? Takeda Oncology
Savi Chadha ? Supernus Pharmaceuticals
Takara Scott ? Ferring Pharmaceuticals
Yishan Chuang ? Biodesix

MSL Rookie of the Year
Andrea Arlia Ciommo ? Janssen
Audra Johnson ? Alimera Sciences
Christelle Chacar ? Ferring Pharmaceuticals
Jason Howard ? Sanofi Genzyme
Jonathan Margolin ? Organogenesis
Jonathan Ploeger ? Astellas Pharma
Keelin Dahl ? Aurinia Pharmaceuticals
Meredith Hart ? Fresenius Kabi 
Ryan Hinman ? Takeda Oncology
Shelley Brown ? Vericel Corporation
Tiyeko Teixeira ? Merck

Submissions were evaluated by nine volunteer judges
Arthur Chan, Executive Director, Head of MSL Capabilities ? Novartis
Donna Holder, Executive Director, GMA Field Medical Center of Excellence ? Merck
Ralph Rewers, Sr. Director Global Field Medical Excellence ? AbbVie
Linda Traylor, Clinical Development & Medical Affairs ? Biodesix 
Larry Dollar, VP of Medical Affairs ? Syneos Health
Davida White, Head, US Medical Affairs ? Indivior
Douglas Yau, Director Oncology Field Medical Affairs ? Sanofi Genzyme
Ellen Shannon, US Head of Medical Affairs ? Valneva
Cherie Hyder, Field Medical Director ? Biohaven Pharmaceuticals

Dr. Samuel Dyer, CEO, MSL Society commented: "We received 159 very impressive applications this year and we are proud to offer these unique awards. We congratulate all the finalists, and look forward to announcing the winners on September 4th."

The 7th Annual MSL Society Conference will take place in Las Vegas September 3-5, 2019 and will be the largest gathering of MSLs in the world. Additional information is available at https://themsls.org/las-vegas-2019/.

Contact: [email protected]

Related Links 

http://www.themsls.org

SOURCE Medical Science Liaison Society


These press releases may also interest you

at 03:00
Todd Britten, DMD, a board-certified periodontist and dental implant specialist in...

at 03:00
SK chemicals (CEO Ahn Jae-hyun), Dongsung Chemical (Co-CEOs Baek Jin-woo and Lee Man-woo), and BYN Black Yak (Chairman Kang Tae-sun, hereinafter Black Yak) announced on the 18th that they've developed sustainable footwear materials using the...

at 02:55
First quarter  Sales of SEK 841 (854) million, a flat growth in local currencies and a decrease of 2% in SEK.Sales per region, in local currencies was +19% in APAC, -2% in EMEA and -14% in Americas.Sales per business area, in local currencies was...

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...



News published on and distributed by: